These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2106 related articles for article (PubMed ID: 32063040)

  • 21. Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.
    Mehta SR; Wood DA; Meeks B; Storey RF; Mehran R; Bainey KR; Nguyen H; Bangdiwala SI; Cairns JA;
    Am Heart J; 2019 Sep; 215():157-166. PubMed ID: 31326681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).
    Pandey A; McGuire DK; de Lemos JA; Das SR; Berry JD; Brilakis ES; Banerjee S; Marso SP; Barsness GW; Simon DN; Roe M; Goyal A; Kosiborod M; Amsterdam EA; Kumbhani DJ
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):197-205. PubMed ID: 27166210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left main percutaneous coronary intervention in ACS or stable coronary artery disease: acute and long-term results.
    Varani E; Vecchio S; Aquilina M; Vecchi G; Balducelli M; Frassineti V; Margheri M
    Minerva Cardioangiol; 2016 Feb; 64(1):23-33. PubMed ID: 26989947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
    Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
    JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous Coronary Intervention for Left Main Coronary Disease in New Zealand: National Linkage Study of Characteristics and In-Hospital Outcomes (ANZACS-QI 38).
    Wang TKM; Kerr A; Kasargod C; Chan D; Cicovic S; Dimalapang E; Webster M; Somaratne J
    Cardiovasc Revasc Med; 2020 May; 21(5):573-579. PubMed ID: 31481307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
    Fukutomi M; Toriumi S; Ogoyama Y; Oba Y; Takahashi M; Funayama H; Kario K
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):E262-E268. PubMed ID: 30244539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcomes of in-hospital staged revascularization versus culprit-only intervention for patients with ST-segment elevation myocardial infarction and multivessel disease.
    Cui K; Lyu S; Song X; Liu H; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Dai J; Tian J
    Coron Artery Dis; 2019 May; 30(3):188-195. PubMed ID: 30724818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
    Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease.
    Vora AN; Wang TY; Hellkamp AS; Thomas L; Henry TD; Goyal A; Roe MT
    Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):513-22. PubMed ID: 27601458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of contrast-induced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data.
    Chatterjee S; Kundu A; Mukherjee D; Sardar P; Mehran R; Bashir R; Giri J; Abbott JD
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):205-212. PubMed ID: 28112470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Cognitive Impairment With Treatment and Outcomes in Older Myocardial Infarction Patients: A Report From the NCDR Chest Pain-MI Registry.
    Bagai A; Chen AY; Udell JA; Dodson JA; McManus DD; Maurer MS; Enriquez JR; Hochman J; Goyal A; Henry TD; Gulati M; Garratt KN; Roe MT; Alexander KP
    J Am Heart Assoc; 2019 Sep; 8(17):e012929. PubMed ID: 31462138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial.
    Obayashi Y; Natsuaki M; Watanabe H; Morimoto T; Yamamoto K; Nishikawa R; Ando K; Suwa S; Isawa T; Takenaka H; Ishikawa T; Tokuyama H; Sakamoto H; Fujita T; Nanasato M; Okayama H; Nishikura T; Kirigaya H; Nishida K; Ono K; Kimura T;
    Eur Heart J Cardiovasc Pharmacother; 2024 Aug; 10(5):374-390. PubMed ID: 38285607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.
    Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S
    Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes after culprit-only percutaneous coronary intervention for multivessel disease during ST-segment elevation myocardial infarction: a comparison of registry and clinical trial outcomes.
    Jackson MWP; Austin D; Swanson N; Williams PD; Muir DF; Hall JA; Wright RA; Sutton AGC; Carter J; de Belder MA
    Coron Artery Dis; 2018 Nov; 29(7):564-572. PubMed ID: 29944476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Outcome of Acute Coronary Syndromes in Patients on Chronic Oral Anticoagulants: Data from the EPICOR Study.
    Stepinska J; Wojtkowska I; Annemans L; Danchin N; Pocock SJ; de Werf FV; Medina J; Bueno H
    Curr Vasc Pharmacol; 2020; 18(1):92-99. PubMed ID: 30588886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Bangalore S; Toklu B; Stone GW
    Am J Cardiol; 2018 Mar; 121(5):529-536. PubMed ID: 29304995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 106.